Area of research
Pathology and Forensic Medicine · Hepatology
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Liver physiology and pathology, Advanced Radiotherapy Techniques, and Organ Transplantation Techniques and Outcomes.
Hepatic stellate cells control liver zonation, size and functions via R-spondin 3
Impact of comorbidities on treatment management and prognosis in patients with anaplastic thyroid cancer (ATC)
Comparison of survival and progression after focal- or whole brain radiotherapy in patients with primary CNS lymphoma – Results from a large multicenter analysis of the German Society of Radiation Oncology’s Neuro-Radio-Oncology Working Group (DEGRO AG-NRO)
The new German evidence-based guideline on diffuse large B-cell lymphoma—key aspects for radiation oncologists
Current situation in radiation oncology residency—Results of a national survey performed by the working group Young DEGRO of the German Society of Radiation Oncology
Radiation Therapy in the German Hodgkin Study Group HD 16 and HD 17 Trials: Quality Assurance and Dosimetric Analysis for Hodgkin Lymphoma in the Modern Era
P092: Estimating the dosimetric benefit of involved-node radiotherapy in comparison to involved-field radiotherapy - implications from the GHSG HD 17 trial
Nuclear factor erythroid 2–related factor 2 and β‐Catenin Coactivation in Hepatocellular Cancer: Biological and Therapeutic Implications
Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations
Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer—results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group
Correction to: Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer—results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group
Quality of teaching radiation oncology in Germany—where do we stand?
Radiation treatment of hemato-oncological patients in times of the COVID-19 pandemic
Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin Mutations
Targeting β‐catenin in hepatocellular cancers induced by coexpression of mutant β‐catenin and K‐Ras in mice